180 related articles for article (PubMed ID: 16774039)
1. Pathways for oxidation of high-density lipoprotein in human cardiovascular disease.
Shao B; Oda MN; Vaisar T; Oram JF; Heinecke JW
Curr Opin Mol Ther; 2006 Jun; 8(3):198-205. PubMed ID: 16774039
[TBL] [Abstract][Full Text] [Related]
2. Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL.
Shao B
Biochim Biophys Acta; 2012 Mar; 1821(3):490-501. PubMed ID: 22178192
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.
Shao B; Oda MN; Bergt C; Fu X; Green PS; Brot N; Oram JF; Heinecke JW
J Biol Chem; 2006 Apr; 281(14):9001-4. PubMed ID: 16497665
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport.
Shao B; Bergt C; Fu X; Green P; Voss JC; Oda MN; Oram JF; Heinecke JW
J Biol Chem; 2005 Feb; 280(7):5983-93. PubMed ID: 15574409
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export.
Shao B; Tang C; Heinecke JW; Oram JF
J Lipid Res; 2010 Jul; 51(7):1849-58. PubMed ID: 20064972
[TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein.
Shao B; Oda MN; Oram JF; Heinecke JW
Curr Opin Cardiol; 2006 Jul; 21(4):322-8. PubMed ID: 16755201
[TBL] [Abstract][Full Text] [Related]
7. Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway.
Shao B; Heinecke JW
J Proteomics; 2011 Oct; 74(11):2289-99. PubMed ID: 21501700
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.
Zheng L; Nukuna B; Brennan ML; Sun M; Goormastic M; Settle M; Schmitt D; Fu X; Thomson L; Fox PL; Ischiropoulos H; Smith JD; Kinter M; Hazen SL
J Clin Invest; 2004 Aug; 114(4):529-41. PubMed ID: 15314690
[TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein.
Shao B; Oda MN; Oram JF; Heinecke JW
Chem Res Toxicol; 2010 Mar; 23(3):447-54. PubMed ID: 20043647
[TBL] [Abstract][Full Text] [Related]
10. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.
Bergt C; Pennathur S; Fu X; Byun J; O'Brien K; McDonald TO; Singh P; Anantharamaiah GM; Chait A; Brunzell J; Geary RL; Oram JF; Heinecke JW
Proc Natl Acad Sci U S A; 2004 Aug; 101(35):13032-7. PubMed ID: 15326314
[TBL] [Abstract][Full Text] [Related]
11. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
[TBL] [Abstract][Full Text] [Related]
12. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.
Shao B; Tang C; Sinha A; Mayer PS; Davenport GD; Brot N; Oda MN; Zhao XQ; Heinecke JW
Circ Res; 2014 May; 114(11):1733-42. PubMed ID: 24647144
[TBL] [Abstract][Full Text] [Related]
13. Myeloperoxidase Targets Apolipoprotein A-I for Site-Specific Tyrosine Chlorination in Atherosclerotic Lesions and Generates Dysfunctional High-Density Lipoprotein.
Jin Z; Zhou L; Tian R; Lu N
Chem Res Toxicol; 2021 Jun; 34(6):1672-1680. PubMed ID: 33861588
[TBL] [Abstract][Full Text] [Related]
14. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages.
Zheng L; Settle M; Brubaker G; Schmitt D; Hazen SL; Smith JD; Kinter M
J Biol Chem; 2005 Jan; 280(1):38-47. PubMed ID: 15498770
[TBL] [Abstract][Full Text] [Related]
15. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.
Shao B; Pennathur S; Heinecke JW
J Biol Chem; 2012 Feb; 287(9):6375-86. PubMed ID: 22219194
[TBL] [Abstract][Full Text] [Related]
16. Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.
Shao B; Fu X; McDonald TO; Green PS; Uchida K; O'Brien KD; Oram JF; Heinecke JW
J Biol Chem; 2005 Oct; 280(43):36386-96. PubMed ID: 16126721
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein.
Lu N; Xie S; Li J; Tian R; Peng YY
Clin Chim Acta; 2015 Feb; 441():163-70. PubMed ID: 25528002
[TBL] [Abstract][Full Text] [Related]
18. Formation of dysfunctional high-density lipoprotein by myeloperoxidase.
Nicholls SJ; Zheng L; Hazen SL
Trends Cardiovasc Med; 2005 Aug; 15(6):212-9. PubMed ID: 16182131
[TBL] [Abstract][Full Text] [Related]
19. Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1.
Cavelier C; Lorenzi I; Rohrer L; von Eckardstein A
Biochim Biophys Acta; 2006 Jul; 1761(7):655-66. PubMed ID: 16798073
[TBL] [Abstract][Full Text] [Related]
20. Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway.
Shao B; Pennathur S; Pagani I; Oda MN; Witztum JL; Oram JF; Heinecke JW
J Biol Chem; 2010 Jun; 285(24):18473-84. PubMed ID: 20378541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
